Panel: The patient precedence: What patients are still telling us about access failures and what must change next

‘We are still waiting’: What patients and caregivers across Europe experience today - from diagnosis delays to eligibility dead-ends and why ATMP access remains inconsistent despite scientific progress.

Eligibility designed without patients: How trial criteria, referral pathways and hospital readiness exclude real-world patients and what can be redesigned now to reflect lived reality.

Value through the patient lens: How patients define meaningful outcomes versus how systems pay for ATMPs and how this disconnect continues to delay access.

From empathy to execution: What developers, regulators, hospitals and sponsors can commit to in the next 12 months to shorten time to treatment without compromising safety